Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director
|
Actinium Pharmaceuticals, Inc. (ATNM)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/25/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
03/31/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
07/13/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
06/16/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
05/08/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
03/15/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
03/16/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
03/16/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
03/11/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
03/16/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
04/10/2014 |
10-K/A
| Annual Report for the period ended December 31, 2013 [amend] |
02/28/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
03/29/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
04/12/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
03/03/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
03/16/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
12/28/2009 |
10-K/A
| Annual Report for the period ended December 31, 2008 [amend] |
02/20/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
|
|